21/09/2022
21/09/2022
Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework
Do you like it?
Read more
21/09/2022
21/09/2022
Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet
Do you like it?
Read more
21/09/2022
21/09/2022
Factsheet – Sustainable Investment and the EU Bioeconomy
Do you like it?
Read more
25/04/2022
25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

Do you like it?
Read more
08/09/2021
08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

Do you like it?
Read more
20/07/2021
20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

Do you like it?
Read more
12/02/2021
12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.
Do you like it?
Read more
Become a member